FDA Announces Draft Guidance on Sex Differences in Medical Product Clinical Trials

Summary

The FDA is releasing a draft guidance to encourage the inclusion of more female participants in clinical trials and to provide recommendations for analyzing sex-specific data, as part of its efforts to improve the generalizability of medical product results.